Could statin use Be associated with reduced recurrence rates following coiling in ruptured intracranial aneurysms?

Waleed Brinjikji, V. Shahi, H. J. Cloft, G. Lanzino, David F Kallmes, Ramanathan D Kadirvel

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: A number of studies have examined the role of matrix metalloproteinases in aneurysm healing following endovascular coiling. Because ruptured aneurysms are known to express higher levels of matrix metalloproteinases, we hypothesized that patients with subarachnoid hemorrhage who were on a statin at the time of coil embolization would have lower aneurysm recanalization and retreatment rates than patients not on statins. MATERIALS AND METHODS: We performed a retrospective chart review of patients who underwent intrasaccular coil embolization of ruptured intracranial aneurysms of≤10mm with at least 6 months of imaging follow-up. Patients were separated into 2 groups: 1) those on an oral statin medication at the time of coiling, and 2) those who were not. Outcomes studied were aneurysm recurrence and aneurysm retreatment after endovascular coiling. Student t and X2 tests were used for statistical significance of differences between groups. RESULTS: One hundred thirty-two patients with 132 ruptured aneurysms were included in our study. Sixteen were on statins (12.1%) and 116 were not (87.9%). The recurrence rate was 6.3% in the statin group (1/16) and 36.2% in the nonstatin group (42/107) (P = .02). Unplanned retreatment rates were 6.3% (1/16) for the statin group and 25.9% (30/116) for the nonstatin group (P = .08). CONCLUSIONS: Statins were associated with a lower rate of aneurysm recurrence following endovascular coiling of small- and mediumsized ruptured aneurysms in this small retrospective study. Further studies are needed to confirm this finding to determine whether statins can be used to reduce recurrence rates in these aneurysms.

Original languageEnglish (US)
Pages (from-to)2104-2107
Number of pages4
JournalAmerican Journal of Neuroradiology
Volume36
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Ruptured Aneurysm
Intracranial Aneurysm
Aneurysm
Recurrence
Retreatment
Matrix Metalloproteinases
Subarachnoid Hemorrhage
Retrospective Studies
Students

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging

Cite this

Could statin use Be associated with reduced recurrence rates following coiling in ruptured intracranial aneurysms? / Brinjikji, Waleed; Shahi, V.; Cloft, H. J.; Lanzino, G.; Kallmes, David F; Kadirvel, Ramanathan D.

In: American Journal of Neuroradiology, Vol. 36, No. 11, 01.11.2015, p. 2104-2107.

Research output: Contribution to journalArticle

@article{ee2fc4c7a4bb45d2b9ba58dc7e22ee47,
title = "Could statin use Be associated with reduced recurrence rates following coiling in ruptured intracranial aneurysms?",
abstract = "BACKGROUND AND PURPOSE: A number of studies have examined the role of matrix metalloproteinases in aneurysm healing following endovascular coiling. Because ruptured aneurysms are known to express higher levels of matrix metalloproteinases, we hypothesized that patients with subarachnoid hemorrhage who were on a statin at the time of coil embolization would have lower aneurysm recanalization and retreatment rates than patients not on statins. MATERIALS AND METHODS: We performed a retrospective chart review of patients who underwent intrasaccular coil embolization of ruptured intracranial aneurysms of≤10mm with at least 6 months of imaging follow-up. Patients were separated into 2 groups: 1) those on an oral statin medication at the time of coiling, and 2) those who were not. Outcomes studied were aneurysm recurrence and aneurysm retreatment after endovascular coiling. Student t and X2 tests were used for statistical significance of differences between groups. RESULTS: One hundred thirty-two patients with 132 ruptured aneurysms were included in our study. Sixteen were on statins (12.1{\%}) and 116 were not (87.9{\%}). The recurrence rate was 6.3{\%} in the statin group (1/16) and 36.2{\%} in the nonstatin group (42/107) (P = .02). Unplanned retreatment rates were 6.3{\%} (1/16) for the statin group and 25.9{\%} (30/116) for the nonstatin group (P = .08). CONCLUSIONS: Statins were associated with a lower rate of aneurysm recurrence following endovascular coiling of small- and mediumsized ruptured aneurysms in this small retrospective study. Further studies are needed to confirm this finding to determine whether statins can be used to reduce recurrence rates in these aneurysms.",
author = "Waleed Brinjikji and V. Shahi and Cloft, {H. J.} and G. Lanzino and Kallmes, {David F} and Kadirvel, {Ramanathan D}",
year = "2015",
month = "11",
day = "1",
doi = "10.3174/ajnr.A4422",
language = "English (US)",
volume = "36",
pages = "2104--2107",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "11",

}

TY - JOUR

T1 - Could statin use Be associated with reduced recurrence rates following coiling in ruptured intracranial aneurysms?

AU - Brinjikji, Waleed

AU - Shahi, V.

AU - Cloft, H. J.

AU - Lanzino, G.

AU - Kallmes, David F

AU - Kadirvel, Ramanathan D

PY - 2015/11/1

Y1 - 2015/11/1

N2 - BACKGROUND AND PURPOSE: A number of studies have examined the role of matrix metalloproteinases in aneurysm healing following endovascular coiling. Because ruptured aneurysms are known to express higher levels of matrix metalloproteinases, we hypothesized that patients with subarachnoid hemorrhage who were on a statin at the time of coil embolization would have lower aneurysm recanalization and retreatment rates than patients not on statins. MATERIALS AND METHODS: We performed a retrospective chart review of patients who underwent intrasaccular coil embolization of ruptured intracranial aneurysms of≤10mm with at least 6 months of imaging follow-up. Patients were separated into 2 groups: 1) those on an oral statin medication at the time of coiling, and 2) those who were not. Outcomes studied were aneurysm recurrence and aneurysm retreatment after endovascular coiling. Student t and X2 tests were used for statistical significance of differences between groups. RESULTS: One hundred thirty-two patients with 132 ruptured aneurysms were included in our study. Sixteen were on statins (12.1%) and 116 were not (87.9%). The recurrence rate was 6.3% in the statin group (1/16) and 36.2% in the nonstatin group (42/107) (P = .02). Unplanned retreatment rates were 6.3% (1/16) for the statin group and 25.9% (30/116) for the nonstatin group (P = .08). CONCLUSIONS: Statins were associated with a lower rate of aneurysm recurrence following endovascular coiling of small- and mediumsized ruptured aneurysms in this small retrospective study. Further studies are needed to confirm this finding to determine whether statins can be used to reduce recurrence rates in these aneurysms.

AB - BACKGROUND AND PURPOSE: A number of studies have examined the role of matrix metalloproteinases in aneurysm healing following endovascular coiling. Because ruptured aneurysms are known to express higher levels of matrix metalloproteinases, we hypothesized that patients with subarachnoid hemorrhage who were on a statin at the time of coil embolization would have lower aneurysm recanalization and retreatment rates than patients not on statins. MATERIALS AND METHODS: We performed a retrospective chart review of patients who underwent intrasaccular coil embolization of ruptured intracranial aneurysms of≤10mm with at least 6 months of imaging follow-up. Patients were separated into 2 groups: 1) those on an oral statin medication at the time of coiling, and 2) those who were not. Outcomes studied were aneurysm recurrence and aneurysm retreatment after endovascular coiling. Student t and X2 tests were used for statistical significance of differences between groups. RESULTS: One hundred thirty-two patients with 132 ruptured aneurysms were included in our study. Sixteen were on statins (12.1%) and 116 were not (87.9%). The recurrence rate was 6.3% in the statin group (1/16) and 36.2% in the nonstatin group (42/107) (P = .02). Unplanned retreatment rates were 6.3% (1/16) for the statin group and 25.9% (30/116) for the nonstatin group (P = .08). CONCLUSIONS: Statins were associated with a lower rate of aneurysm recurrence following endovascular coiling of small- and mediumsized ruptured aneurysms in this small retrospective study. Further studies are needed to confirm this finding to determine whether statins can be used to reduce recurrence rates in these aneurysms.

UR - http://www.scopus.com/inward/record.url?scp=84947439631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947439631&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A4422

DO - 10.3174/ajnr.A4422

M3 - Article

C2 - 26272974

AN - SCOPUS:84947439631

VL - 36

SP - 2104

EP - 2107

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 11

ER -